Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neurotoxicity. - Wikidata - awgldk - TriplyDB

Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neurotoxicity.

Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neurotoxicity.

http://www.wikidata.org/entity/Q37791283

about

Methylene blue for distributive shock: a potential new use of an old antidote Methylene blue induces macroautophagy through 5' adenosine monophosphate-activated protein kinase pathway to protect neurons from serum deprivation Central nervous system toxicities of chemotherapeutic agents.Prenatal effects of transplacental exposure to ifosfamide in rats.Protective effects of caffeic acid phenethyl ester on ifosfamide-induced central neurotoxicity in rats.Methylene blue and its analogues as antidepressant compounds.MEF2D Mediates the Neuroprotective Effect of Methylene Blue Against Glutamate-Induced Oxidative Damage in HT22 Hippocampal Cells.Fluorescence-Guided Surgery.

P2860

Q24624791-49A131FA-BE92-40BA-93B1-04A7E8E687F7 Q36812658-E65A7036-1552-426E-AF90-85A275932AC0 Q38205470-6B95C377-C7D2-43DA-A572-31D2338E3B5D Q42492493-DECAE766-7141-41F4-876C-C8442BC9EC76 Q44873968-57768CDA-7BFF-428D-B048-EC04256E8FAA Q46327960-00EF0265-8EE1-48BE-B278-F29701F87868 Q46585492-6BADA476-A706-47CA-AA46-85428AE2AABB Q49472946-8DE4AFE2-FF4F-4E80-BA64-08311ADB3919

P2860

Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neurotoxicity.

http://www.wikidata.org/entity/Q37791283

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 September 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluation of methylene blue, ...... sfamide-related neurotoxicity.

@en

Evaluation of methylene blue, ...... sfamide-related neurotoxicity.

@nl

type

label

Evaluation of methylene blue, ...... sfamide-related neurotoxicity.

@en

Evaluation of methylene blue, ...... sfamide-related neurotoxicity.

@nl

prefLabel

Evaluation of methylene blue, ...... sfamide-related neurotoxicity.

@en

Evaluation of methylene blue, ...... sfamide-related neurotoxicity.

@nl

P1433

Q37791283-B31E984C-162A-4D83-AD48-7C6C959D994F

P1476

Q37791283-C064B6B7-84E2-4AFF-BC19-2D0742C30617

P2093

Q37791283-26C3001A-C87E-4B44-AE6B-81675F06E258

Q37791283-6B639B5B-325B-4765-AEA3-AD0FF7415BC2

Q37791283-B532D377-F0E7-4185-ABAB-7D5B69D80345

P2860

Q37791283-24991DF0-E16B-47E7-A705-310F271772EB

Q37791283-701831FD-808E-4E5C-8B3C-9745C7F93B02

Q37791283-825681BC-7E25-4D2D-9A8E-0468DC417CB5

Q37791283-8C246DDF-F1D9-4BE5-A037-CFFE75700F7B

Q37791283-AE49105E-1835-425E-A45E-FCA5A9F5CC00

Q37791283-B971F196-A5FA-4276-B5B0-2A496885F199

Q37791283-D47EF2CB-9907-430E-BD7E-80FBE09D9B45

Q37791283-F57D5DC5-16EF-4654-B98F-81CB4BE39E59

Q37791283-F731CD89-9621-45BA-A560-5ADCB8A9D49E

Q37791283-FBBAAC3E-A201-40BC-82B5-28AE646F9D61

P304

Q37791283-1B41CE44-A5CA-417C-8FB9-FE4DC7B1D133

P31

Q37791283-B39EFF1C-FE55-4C12-AD66-C9F47EC8DB08

P356

Q37791283-2DC6D4FA-1C90-4333-A3B9-2156D2346CE9

P433

Q37791283-CA5E96B0-6A57-4FC7-9867-6E786CEB45D9

P478

Q37791283-B6544F6A-93B8-4A28-B861-75B769349FB9

P577

Q37791283-4ED771FE-4FE4-4C61-B255-24D0BBEEE492

P698

Q37791283-39A2FA56-D7C3-4513-B585-A064D8016D07

P921

Q37791283-070D4595-01EB-4501-807F-3C39BC314129

P356

1078155210385159

P1433

Journal of Oncology Pharmacy Practice

P1476

Evaluation of methylene blue, ...... sfamide-related neurotoxicity.

@en

P2093

Amy McQuary

http://www.w3.org/2001/XMLSchema#string

Ashley Richards

http://www.w3.org/2001/XMLSchema#string

Helen Marshall

http://www.w3.org/2001/XMLSchema#string

P2860

Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature

Methylene blue for management of Ifosfamide-induced encephalopathy.

Neurological toxicity of ifosfamide.

Evaluating risk factors for the development of ifosfamide encephalopathy.

Ifosfamide-induced encephalopathy with or without using methylene blue.

Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.

Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.

Suspected ifosfamide-induced neurotoxicity.

Possible contribution of aprepitant to ifosfamide-induced neurotoxicity.

Role of thiamine in managing ifosfamide-induced encephalopathy.

P304

372-380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1078155210385159

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20861178

http://www.w3.org/2001/XMLSchema#string

P921